Statistics for PolyPeptide Group AG (id:13100 PPGN)
Valuation metrics
Market cap
949.93M
Enterprise value
952.31M
Trailing P/E (ttm)
108.52
Forward P/E
77.84
PEG ratio
77.84
Price/Sales (ttm)
2.94
Price/Book (mrq)
2.64
Enterprise Value/Revenue
3.14
Enterprise Value/EBITDA
2.28K
Overview
Shares outstanding
32.98M
Float
12.96M
Shares short
% Held by insiders
0.60%
% Held by institutions
0.20%
Average volume (10 days)
20.15K
Average volume (90 days)
Price summary
52-Week low
14.11
52-Week high
35.80
52-Week change
33.70%
Beta
1.12
50-Day moving average
30.26
200-Day moving average
28.48
Dividends and splits
Forward annual dividend rate
1.20
Forward annual dividend yield
0.04
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
May 02th, 2022
Ex-dividend date
April 28th, 2022
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
December 31th, 2023
Profitability
Profit margin
-8.83%
Operating margin
-9.31%
Operational effectiveness
Return on assets
-2.34%
Return on equity
-7.68%
Income statement
Revenue (ttm)
9.89
Revenue per share (ttm)
9.89
Quarterly revenue growth (yoy)
Gross profit (ttm)
4.64M
EBITDA
418.46K
Net income to common (ttm)
-26,736,444.00
Diluted EPS (ttm)
-0.81
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
45.38M
Total cash per share (mrq)
1.47
Total debt (mrq)
108.42M
Total Debt/Equity (mrq)
32.18
Current ratio (mrq)
159.40%
Book value per share (mrq)
10.91
Cash flow
Cash flow statement
79.83M
Levered free cash flow (LFCF)
9.56M